FR2390960B1 - Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique - Google Patents

Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique

Info

Publication number
FR2390960B1
FR2390960B1 FR7814450A FR7814450A FR2390960B1 FR 2390960 B1 FR2390960 B1 FR 2390960B1 FR 7814450 A FR7814450 A FR 7814450A FR 7814450 A FR7814450 A FR 7814450A FR 2390960 B1 FR2390960 B1 FR 2390960B1
Authority
FR
France
Prior art keywords
inhibiting
oxygen
application
acid biosynthesis
mevalonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7814450A
Other languages
English (en)
Other versions
FR2390960A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHROEPFER JOHN
Original Assignee
SCHROEPFER JOHN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHROEPFER JOHN filed Critical SCHROEPFER JOHN
Publication of FR2390960A1 publication Critical patent/FR2390960A1/fr
Application granted granted Critical
Publication of FR2390960B1 publication Critical patent/FR2390960B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7814450A 1977-05-16 1978-05-16 Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique Expired FR2390960B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/797,345 US4202891A (en) 1977-05-16 1977-05-16 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols

Publications (2)

Publication Number Publication Date
FR2390960A1 FR2390960A1 (fr) 1978-12-15
FR2390960B1 true FR2390960B1 (fr) 1985-11-29

Family

ID=25170577

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7814450A Expired FR2390960B1 (fr) 1977-05-16 1978-05-16 Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique
FR8116129A Pending FR2485021A1 (fr) 1977-05-16 1981-08-21 Nouveaux sterols 15-oxygenes

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8116129A Pending FR2485021A1 (fr) 1977-05-16 1981-08-21 Nouveaux sterols 15-oxygenes

Country Status (11)

Country Link
US (1) US4202891A (fr)
JP (1) JPS5455734A (fr)
AU (1) AU520703B2 (fr)
BE (1) BE867120A (fr)
CA (1) CA1123739A (fr)
CH (1) CH641352A5 (fr)
DE (3) DE2821242A1 (fr)
FR (2) FR2390960B1 (fr)
GB (1) GB1599863A (fr)
IT (1) IT1156745B (fr)
NL (1) NL7805267A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563000A (en) * 1979-06-20 1981-01-13 Green Cross Corp:The Water-soluble cholesterol derivative
ES2046217T3 (es) * 1987-01-30 1994-02-01 The Du Pont Merck Pharmaceutical Company Lanosteroles 14,15-sustituidos y su uso como agentes hipocolesterolemicos.
US5034548A (en) * 1987-01-30 1991-07-23 E. I. Du Pont De Nemours And Company Steroid derivatives useful as hypocholesterolemics
US5041432A (en) * 1987-01-30 1991-08-20 E. I. Du Pont De Nemours And Company Steroid derivatives useful as hypocholesterolemics
DE3705990A1 (de) * 1987-02-20 1988-09-01 Schering Ag 1-methyl-15(alpha)-(1-oxyalkyl)-androsta-1,4-dien- 3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4897475A (en) * 1988-02-05 1990-01-30 William Marsh Rice University Process for synthesis of 5α-cholest-8(14)-en-3β-ol-15-one and other 15-oxygenated sterols
US4900477A (en) * 1988-03-28 1990-02-13 American Cyanamid Company Novel intermediates and an improved process for producing the compound (3β,5α)-3-hydroxycholest-8(14)-en-15-one
US5023250A (en) * 1989-08-24 1991-06-11 Smithkline Beecham Corporation Steroidal 14α-carboxy-alkyl derivatives as regulators of HMG-COA reductase
US5219879A (en) * 1990-03-05 1993-06-15 Du Pont Merck Pharmaceutical Company Heterocyclic steroid compounds
JP3029907B2 (ja) * 1991-12-20 2000-04-10 理化学研究所 抗肥満剤
US5510340A (en) * 1992-06-12 1996-04-23 Sri International Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
US5371077A (en) * 1992-08-03 1994-12-06 William Marsh Rice University Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
JP2002544136A (ja) * 1999-05-10 2002-12-24 シエーリング アクチエンゲゼルシャフト １４β−Ｈ−ステロール類、それらを含んで成る医薬組成物、及び減数分裂調節医薬の調節のためのそれらの誘導体の使用
WO2006047022A1 (fr) 2004-10-25 2006-05-04 Virginia Commonwealth University Oxysterol sulfate nucleaire, regulateur homeostatique du cholesterol agissant puissamment dans le traitement de l'hypercholesterolemie, de l'hyperlipidemie et de l'atherosclerose
US8399441B2 (en) * 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
CA3195252A1 (fr) 2013-12-24 2015-07-02 Durect Corporation Utilisations de sulfates de cholesterol oxygenes (ocs)
PL3494125T3 (pl) 2016-08-02 2022-10-17 Virginia Commonwealth University Kompozycje zawierające 3-siarczan 5-cholesten-3,25-diolu (25hc3s) lub farmaceutycznie dopuszczalną sól i co najmniej jeden cykliczny oligosacharyd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1080333A (en) * 1963-11-01 1967-08-23 Takeda Chemical Industries Ltd New 14-hydroxy steroids
US3354154A (en) * 1966-01-26 1967-11-21 Syntex Corp 2beta, 3beta-alkylidenedioxy-6-hydroxy-22, 23-bisnorchol-7-enoic acid alkyl esters and process for the production thereof

Also Published As

Publication number Publication date
BE867120A (fr) 1978-09-18
DE2858802C2 (de) 1991-10-02
IT1156745B (it) 1987-02-04
GB1599863A (en) 1981-10-07
CH641352A5 (de) 1984-02-29
AU3616778A (en) 1979-11-22
JPH0214329B2 (fr) 1990-04-06
FR2485021A1 (fr) 1981-12-24
DE2821242C2 (fr) 1991-10-24
DE2858726C2 (de) 1992-10-01
DE2821242A1 (de) 1978-11-23
JPS5455734A (en) 1979-05-04
US4202891A (en) 1980-05-13
IT7849386A0 (it) 1978-05-16
CA1123739A (fr) 1982-05-18
FR2390960A1 (fr) 1978-12-15
AU520703B2 (en) 1982-02-25
NL7805267A (nl) 1978-11-20

Similar Documents

Publication Publication Date Title
FR2390960B1 (fr) Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique
NZ195517A (en) Imidazole-5-acetic acid derivatives and pharmaceutical compositions
BE863429A (fr) Derives de l'acide quinoleine-carboxylique
IT1148006B (it) Ammidi dotate di proprieta' farmaceutiche e loro preparazione
PH13569A (en) Imidazolidine derivatives and pharmaceutical compositions containing the same
IT7853418V0 (it) Pporto per deodoranti da applicare ai vasi di gabinetti e simili
BE870796A (fr) Derives alpha-halogenomethyles de l'acide gamma-aminobutyrique, leur preparation et leur utilisation
IT8068211A0 (it) Composti utilizzabili come agenti inibitori della biosintesi del colesterolo e procedimento per la loro preparazione
FR2645153B1 (fr) Derives de la thieno-triazolo-diazepine ainsi que leur procede de preparation
IT8547538A0 (it) 8 alfa-acilamminoergoline,loro preparazione e loro impiego come medicamenti
IT8048615A0 (it) Pirazinobenzodiazepine loro preparazione e loro impiego come medicamenti
IT1106299B (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonch' composizioni farmaceutiche che la contengono
ZA806028B (en) 2-substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acid and derivatives thereof as safening agents
ZA784969B (en) 2-hydrazonopropionic acid derivatives and the preparation thereof
IT8022677A0 (it) Sostanze dotate di attivita'antispastica vasale e procedimenti per la loro preparazione.
BE862506A (fr) Derives de l'anthranilate de n-benzoyle et leur application en tant que fongicides
FR2449686B1 (fr) Nouvel ester de l'acide 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetique et sa preparation, ainsi que medicament le comprenant et sa preparation
NZ188101A (en) N-substituted-2-aminobenzoic acid derivatives and pharmaceutical compositions
BE883943A (fr) Derives de l'enkaphaline, leur preparation et leurs utilisations therapeutiques, notamment comme analgesiques
IT1200163B (it) 8alfa-acilamminoergoline, loro preparazione e composizioni farmaceutiche che le contengono
IT1094627B (it) 17 beta-idrossi-4-androsten-3-oni e procedimento per la loro preparazione
IT1118225B (it) Procedimento per l'ottenimento di steroidi poliossidrilati,lisergolo ed alcaloidi ergolici
IT1092719B (it) Pigmenti monoazoici e procedimento per la loro preparazione
IL53342A (en) Monocyclic -lactams,their preparation and pharmaceutical compositions containing -lactams having anitbacterial activite
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques

Legal Events

Date Code Title Description
ST Notification of lapse